Short and long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel following percutaneous coronary intervention: Results from CREDO

被引：0
|
作者：
Beinart, S
Kolm, P
Veledar, E
Zhang, ZF
Mahoney, E
Gabriel, S
Steinhubl, S
Weintraub, WS
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Sanofi Synthelabo, Paris, France
[3] Univ N Carolina, Chapel Hill, NC 27599 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3495
引用
收藏
页码：775 / 775
页数：1
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Prolonged Dual Antiplatelet Therapy according to Baseline Anemia after Percutaneous Coronary Intervention
    Kim, Hun-Tae
    Lee, Jung-Hee
    Nam, Jong-Ho
    Lee, Chan-Hee
    Son, Jang-Won
    Kim, Ung
    Park, Jong-Seon
    Shin, Dong-Gu
    YONSEI MEDICAL JOURNAL, 2022, 63 (03) : 211 - 219
  • [32] Current Status of Long-Term Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention in Japan: Findings From the National Database
    Kanaoka, Koshiro
    Terasaki, Satoshi
    Nishioka, Yuichi
    Kubo, Shinichiro
    Myojin, Tomoya
    Soeda, Tsunenari
    Noda, Tatsuya
    Watanabe, Makoto
    Kawakami, Rika
    Imamura, Tomoaki
    Saito, Yoshihiko
    CIRCULATION, 2019, 140
  • [33] Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
    Aronow, Herbert D.
    Steinhubl, Steven R.
    Brennan, Danielle M.
    Berger, Peter B.
    Topol, Eric J.
    AMERICAN HEART JOURNAL, 2009, 157 (02) : 369 - 374
  • [34] Long-Term Results Following Switch From Abciximab to Eptifibatide During Percutaneous Coronary Intervention
    Koutouzis, Michael
    Lagerqvist, Bo
    Oldgren, Jonas
    Akerblom, Axel
    Wahlin, Magnus
    Karlsson, Thomas
    Albertsson, Per
    Matejka, Goran
    Grip, Lars
    CLINICAL CARDIOLOGY, 2010, 33 (11) : 686 - 692
  • [35] The efficacy of statin therapy on long-term outcomes following percutaneous coronary intervention
    Kasai, T
    Miyauchi, K
    Kurata, T
    Satoh, H
    Ohta, H
    Shimada, K
    Okazaki, S
    Yokoyama, K
    Kojima, T
    Akimoto, Y
    Miyazaki, T
    Daida, H
    CIRCULATION, 2004, 110 (17) : 491 - 491
  • [36] Statin therapy and long-term clinical outcomes following percutaneous coronary intervention
    Chan, B. R.
    Brownell, B.
    Love, M. P.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 79C - 79C
  • [37] Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes
    Sidhu, Mandeep S.
    Lyubarova, Radmila
    Bangalore, Sripal
    Bonaca, Marc P.
    AMERICAN HEART JOURNAL, 2022, 246 : 44 - 64
  • [38] LONG-TERM OUTCOME OF USE OF ORAL ANTICOAGULANTS WITH DUAL ANTIPLATELET THERAPY IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION AND NEW ONSET SYSTOLIC DYSFUNCTION
    Negi, Smita
    Baker, Nevin
    Lipinski, Michael
    Lhermusier, Thibault
    Ota, Hideaki
    Kiramijyan, Sarkis
    Koifman, Edward
    Alarcon, Ricardo Escarcega
    Pereira, Marco Magalhaes
    Torguson, Rebecca
    Ben-Dor, Itsik
    Suddath, William
    Pichard, Augusto
    Satler, Lowell
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1849 - A1849
  • [39] Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients
    Kim, Dong-Yeon
    Cho, Sung Woo
    Park, Kyu Tae
    Ahn, Jong-Hwa
    Park, Taek Kyu
    Jang, Yong Ho
    Choi, Ki Hong
    Lee, Joo Myung
    Yang, Jeong Hoon
    Song, Young Bin
    Choi, Jin-Ho
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Lee, Sang Hoon
    Hahn, Joo-Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (16) : e106
  • [40] Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy
    DeEugenio, Deborah
    Kolman, Louis
    DeCaro, Matthew
    Andrel, Jocelyn
    Chervoneva, Inna
    Duong, Phu
    Lam, Linh
    McGowan, Christopher
    Lee, Grace
    DeCaro, Mark
    Ruggiero, Nicholas
    Singhal, Shalabh
    Greenspon, Arnold
    PHARMACOTHERAPY, 2007, 27 (05): : 691 - 696
12345